on 16 Jul 2019
Last Applicant/ Owned by
2440 Research Boulevard
Rockville
MD
20850
Serial Number
86463776 filed on 24th Nov 2014
Registration Number
5807079 registered on 16th Jul 2019
Correspondent Address
B. Brett Heavner
B. BRETT HEAVNER FINNEGAN, HENDERSON, FARABOW, GARRETT AND DUNNER,
WASHINGTON, DC 20001-4432
UNITED STATES
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Providing patient support in the nature of information about the location of medical treatment facilities for central nervous system diseases and disorders and for vasopressin receptor antagonist responsive diseases and disorders; providing medical information to medical professionals in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist Read More
Providing patient support in the nature of information about the location of medical treatment facilities for central nervous system diseases and disorders and for vasopressin receptor antagonist responsive diseases and disorders; providing medical information to medical professionals in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders; providing a website for medical professionals featuring medical information in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders
24th Nov 2014
24th Nov 2014
Educational services, namely, conducting educational programs and providing courses about central nervous system diseases, disorders and treatment; on-line publishing of electronic publications; on-line journals, namely, blogs about central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment
24th Nov 2014
24th Nov 2014
Providing financial information about reimbursement for medical expenses for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical benefit verification and prior authorization services for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical records coding, billing, and compliance for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders
24th Nov 2014
24th Nov 2014
Promoting awareness of patient support offerings for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment; discharge planning support, namely, providing consumer information to patients about health care plan options, products and programs in the field of managed care and state and federal medical care programs for central nervous system diseases, disorders and treatment and for vasopressin receptor antagonist responsive diseases, disorders, and treatment
24th Nov 2014
24th Nov 2014
Printed materials, namely, brochures, pamphlets and posters about patient support for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment
24th Nov 2014
24th Nov 2014
No 86463776
No Service Mark
No 09843.0076
No
No
No
No
No
No
No
No
26.05.21 -
Triangles that are completely or partially shaded
Status Date | Action Taken |
---|---|
16th Jul 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
16th Jul 2019 | EXPARTE APPEAL TERMINATED |
16th Jul 2019 | REGISTERED-PRINCIPAL REGISTER |
08th Jul 2019 | ASSIGNED TO EXAMINER |
11th Jun 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
09th Jun 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
17th May 2019 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
25th Mar 2019 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED |
25th Mar 2019 | ACTION DENYING REQ FOR RECON E-MAILED |
25th Mar 2019 | SU - ACTION CONTINUING FINAL - WRITTEN |